Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Two antibiotics fight bacteria differently than thought

02.11.2016

Two widely prescribed antibiotics -- chloramphenicol and linezolid -- may fight bacteria in a different way from what scientists and doctors thought for years, University of Illinois at Chicago researchers have found. Instead of indiscriminately stopping protein synthesis, the drugs put the brakes on the protein synthesis machinery only at specific locations in the gene.

Ribosomes are among the most complex components in the cell, responsible for churning out all the proteins a cell needs for survival. In bacteria, ribosomes are the target of many important antibiotics.


Chloramphenicol, linezolid stall ribosomes at specific mRNA locations.

Credit: Alexander Mankin, UIC

The team of Alexander Mankin and Nora Vazquez-Laslop has conducted groundbreaking research on the ribosome and antibiotics. In their latest study, published in the Proceedings of the National Academy of Sciences, they found that while chloramphenicol and linezolid attack the catalytic center of the ribosome, they stop protein synthesis only at specific checkpoints.

"Many antibiotics interfere with the growth of pathogenic bacteria by inhibiting protein synthesis," says Mankin, director of the UIC Center for Biomolecular Sciences and professor of medicinal chemistry and pharmacognosy. "This is done by targeting the catalytic center of the bacterial ribosome, where proteins are being made. It is commonly assumed that these drugs are universal inhibitors of protein synthesis and should readily block the formation of every peptide bond."

"But -- we have shown that this is not necessarily the case," said Vazquez-Laslop, research associate professor of medicinal chemistry and pharmacognosy.

A natural product, chloramphenicol is one of the oldest antibiotics on the market. For decades it has been useful for many bacterial infections, including meningitis, plague, cholera and typhoid fever.

Linezolid, a synthetic drug, is a newer antibiotic used to treat serious infections -- streptococci and methicillin-resistant Staphylococcus aureus (MRSA), among others -- caused by Gram-positive bacteria that are resistant to other antibiotics. Mankin's previous research established the site of action and mechanism of resistance to linezolid.

While the antibiotics are very different, they each bind to the ribosome's catalytic center, where they were expected to inhibit formation of any peptide bond that links the components of the protein chain into a long biopolymer. In simple enzymes, an inhibitor that invades the catalytic center simply stops the enzyme from doing its job. This, Mankin said, had been what scientists had believed was also true for antibiotics that target the ribosome.

"Contrary to this view, the activity of chloramphenicol and linezolid critically depends on the nature of specific amino acids of the nascent chain carried by the ribosome and by the identity of the next amino acid to be connected to a growing protein," Vazquez-Laslop said. "These findings indicate that the nascent protein modulates the properties of the ribosomal catalytic center and affects binding of its ligands, including antibiotics."

Combining genomics and biochemistry has allowed the UIC researchers to better understand how the antibiotics work.

"If you know how these inhibitors work, you can make better drugs and make them better tools for research," said Mankin. "You can also use them more efficiently to treat human and animal diseases."

###

James Marks, Krishna Kannan, Emily Roncase, Dorota Klepacki, Amira Kefi and Cedric Orelle, all of UIC, are co-authors on the publication. The research was funded by National Institutes of Health grant AI 125518.

Media Contact

Sam Hostettler
samhos@uic.edu
312-355-2522

 @uicnews

http://www.uic.edu 

Sam Hostettler | EurekAlert!

Further reports about: UIC antibiotics drugs infections protein synthesis proteins ribosome synthesis typhoid fever

More articles from Life Sciences:

nachricht New catalyst controls activation of a carbon-hydrogen bond
21.11.2017 | Emory Health Sciences

nachricht The main switch
21.11.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Previous evidence of water on mars now identified as grainflows

21.11.2017 | Physics and Astronomy

NASA's James Webb Space Telescope completes final cryogenic testing

21.11.2017 | Physics and Astronomy

New catalyst controls activation of a carbon-hydrogen bond

21.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>